Biodesix (BDSX) Assets Average (2020 - 2026)

Biodesix has reported Assets Average for 7 years, with the latest figure at $91.1 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 0.75% year-over-year to $91.1 million; the trailing twelve-month figure through Mar 2026 stood at $91.1 million (down 0.75% YoY), and the FY2025 full-year result was $92.4 million, down 5.92% from the prior year.
• Assets Average for Q1 2026 stood at $91.1 million, up from $88.1 million in the prior quarter.
• The five-year high for Assets Average was $109.3 million in Q3 2024, with the low at $68.4 million in Q2 2022.
• Historically, Assets Average has averaged $86.8 million across 5 years, with a median of $88.1 million in 2025.
• Annual changes were most pronounced in 2022 — Assets Average plunged 41.77% — and 2024, when it surged 32.95%.
• Biodesix's Assets Average stood at $78.1 million in 2022, then rose by 19.08% to $92.9 million in 2023, then grew by 7.59% to $100.0 million in 2024, then retreated by 11.9% to $88.1 million in 2025, then climbed by 3.36% to $91.1 million in 2026.
• The last three Assets Average figures came in at $91.1 million (Q1 2026), $88.1 million (Q4 2025), and $88.2 million (Q3 2025), per Business Quant data.